Cardiac Rehabilitation in Patients With Implantable Cardioverter-Defibrillator: A Scoping Review

Carolina Castro Gómez1,2,3, Maria Juliana Devia Quiñonez2, Daniela López Gómez4

  • 1Institución Universitaria Escuela Nacional del Deporte, Cali, Colombia.

Insights

Exercise-based cardiac rehabilitation (CR) is safe for patients with an implantable cardioverter-defibrillator (ICD). CR improves fitness and quality of life without increasing adverse events or device shocks.

Area of Science:

  • Cardiology
  • Sports Medicine
  • Rehabilitation Science

Background:

  • Sudden cardiac death (SCD) is a significant global health concern.
  • Implantable cardioverter-defibrillators (ICDs) are crucial for SCD prevention.
  • Cardiac rehabilitation (CR) programs enhance patient outcomes post-ICD implantation.

Purpose of the Study:

  • To review the outcomes of exercise-based CR in patients with ICDs.
  • To assess the safety and efficacy of CR interventions for ICD recipients.

Main Methods:

  • A scoping review was conducted following established methodologies (JBI, Arksey & O'Malley, Levac et al.).
  • Systematic searches were performed across multiple databases (PubMed, SCOPUS, PEDro, etc.).
  • Included studies focused on exercise-based CR programs for ICD patients.

Main Results:

  • Four studies utilized combined aerobic and strength training programs, typically 12 weeks long.
  • Training intensity was maintained at 50-80% of maximum heart rate, with heart rate targets below ICD activation thresholds.
  • CR improved cardiopulmonary parameters and exercise tolerance without adverse cardiac events or ICD shocks during sessions.

Conclusions:

  • Exercise-based CR is a safe intervention for patients with ICDs.
  • CR leads to significant improvements in VO2, METs, and 6-minute walk distance.
  • CR positively impacts patient quality of life and functional capacity.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
106
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
68
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47